JWCA has advised COHERUS BIOSCIENCES on capital market transactions with OVER $300 MILLION in transaction Value
April 2020: JWCA advises Coherus BioSciences on its $230 million convertible bond and capped call transaction
February 2016: JWCA advises Coherus BioSciences on its $100mm convertible bond execution